Related Experiment Video

Updated: Jun 18, 2025

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.1K

A half-century of VEGFA: from theory to practice

Susan E Quaggin1,2

  • 1Feinberg Cardiovascular & Renal Research Institute, and.

The Journal of Clinical Investigation
|August 1, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.7K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.7K

Related Experiment Videos

Last Updated: Jun 18, 2025

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles
09:01

Programming Stem Cells for Therapeutic Angiogenesis Using Biodegradable Polymeric Nanoparticles

Published on: September 27, 2013

11.1K
A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

9.7K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

7.7K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K

Articles linked to this work by shared authors, journal, and citation graph.

Transcription factor 21 deletion from podocyte precursors as a model for congenital nephrotic syndrome.

American journal of physiology. Renal physiology·2026

Endothelial prolyl hydroxylase 3 mitigates maladaptive inflammation to promote post-ischemic kidney repair.

Kidney international·2026

A Highly Active Angiopoietin 1 Mimetic Potentiates Angiogenesis in Mouse Models of Choroidal Neovascularization.

Translational vision science & technology·2026

The transcription factor Tcf21 is necessary for adoption of cell fates by Foxd1+ stromal progenitors during kidney development.

American journal of physiology. Renal physiology·2026

Piezo1 Activates an Autocrine Angiopoietin-2-Integrin Signaling Loop in Schlemm's Canal to Regulate Intraocular Pressure.

bioRxiv : the preprint server for biology·2025

Enabling organ- and injury-specific nanocarrier targeting via surface-functionalized PEG-b-PPS micelles for acute kidney injury.

Nanoscale horizons·2025

Convection-enhanced delivery of dexamethasone in glioma models suppresses myeloid inflammation while avoiding systemic toxicities.

The Journal of clinical investigation·2026

CD73 inhibition overcomes adaptive immune resistance to PARP inhibiton in models of prostate cancer.

The Journal of clinical investigation·2026

Polycomb Scaffolding Subunit EED Supports the SCLC Neuroendocrine Identity and EGFR-Mutant LUAD to SCLC Transformation.

The Journal of clinical investigation·2026

Radiotherapy and immunotherapy in cancer treatment: mechanisms of clinical synergy.

The Journal of clinical investigation·2026

Emerging roles of ATR beyond DNA damage repair: orchestrating transcriptional reprogramming during epithelial-to-mesenchymal transition.

The Journal of clinical investigation·2026

Monoclonal antibody CIS43LS sets the bar for long-acting malaria protection.

The Journal of clinical investigation·2026

A tribute to Annabella Selloni.

The Journal of chemical physics·2026

Beyond Knower and Known: The Evolution of a Personal Core Theory in "The Imaginer and the Imagined" and Related Works.

The Psychoanalytic quarterly·2026

Who is Missing From the Picture? Recognition, Enactment, and Containment in Lucy Lafarge's "The Imaginer and the Imagined".

The Psychoanalytic quarterly·2026

Transformative caring theory: A theoretical synthesis.

International journal of nursing knowledge·2026

Love-Centered Therapy and the First Story Cycle: A Dyadic Process Model of Implicit Relational Activation, Autonomic Co-Regulation, and Sexual Field Disruption.

Journal of sex & marital therapy·2026

[Thoughts on the deconstruction and reconstruction of jingluo system].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us